Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Durham NC, Cleveland OH, New York NY, Boston MA,
Sponsor: Convergent Therapeutics
Sex: Male
Age: 18+
Code: NCT06549465
Phase 2, Recruiting
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
for
Pompe Disease
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT01665326
Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Durham NC, Chapel Hill NC, Fairfax VA, Baltimore MD,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase 1, Phase 2, Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Durham NC, Myrtle Beach SC, Fairfax VA, Cleveland OH,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase 1, Recruiting
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
for
Advanced Ovarian Carcinoma,
Location: Durham NC, Bethlehem PA, Cleveland OH, New York NY,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT04575935
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
for
Coronary Artery Disease
Location: Durham NC, Lexington KY, Atlanta GA, Columbus OH,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT06399692
Phase 3, Recruiting
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
for
Oligometastasis, Metastatic Cancer
Location: Durham NC, Raleigh NC, Cary NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT04085029
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
for
Intestinal Failure Associated Liver Disease
Location: Durham NC, Atlanta GA, Cleveland OH, New York NY,
Sponsor: NorthSea Therapeutics B.V.
Sex: All
Age: 16+
Code: NCT05919680
Phase 2, Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors